These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32362471)

  • 1. Is a second course of intravenous immunoglobulin treatment in Guillain-Barré syndrome justifiable?
    Yang J; Jia R
    J Clin Neurosci; 2020 Jul; 77():251-252. PubMed ID: 32362471
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoalbuminemia in Guillain-Barré syndrome.
    Jia L; Zhang H
    J Clin Neurosci; 2020 Jul; 77():249-250. PubMed ID: 32362470
    [No Abstract]   [Full Text] [Related]  

  • 3. Albumin levels as a biomarker for second Intravenous Immunoglobulin (IVIG) treatment in Guillain-Barre syndrome (GBS).
    Shalman A; Savir S; Mechnik Steen Y; Ovanyan A; Boniel N; Koyfman L; Bichovsky Y; Zlotnik A; Klein M; Brotfain E
    J Clin Neurosci; 2020 Apr; 74():247-249. PubMed ID: 32088107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could Albumin Be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?
    Wang Y; Zhang HL
    JAMA Neurol; 2017 Jul; 74(7):871-872. PubMed ID: 28505216
    [No Abstract]   [Full Text] [Related]  

  • 5. Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply.
    Fokkink WR; Jacobs BC
    JAMA Neurol; 2017 Jul; 74(7):872. PubMed ID: 28505236
    [No Abstract]   [Full Text] [Related]  

  • 6. IV Immunoglobulin in Guillain-Barré Syndrome: Is It Still Justifiable?
    Angurana SK; Suthar R; Nallasamy K
    Pediatr Crit Care Med; 2019 Oct; 20(10):1002. PubMed ID: 31580281
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; Doorn PA
    Cochrane Database Syst Rev; 2004; (1):CD002063. PubMed ID: 14973982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year prospective study (clinical spectrum) of childhood Guillain-Barré syndrome in the Arabian peninsula: comparison of outcome in patients in the pre- and post-intravenous immunoglobulin eras.
    Koul R; Chacko A; Ahmed R; Varghese T; Javed H; Al-Lamki Z
    J Child Neurol; 2003 Nov; 18(11):767-71. PubMed ID: 14696904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
    Kalita J; Kumar M; Misra UK
    Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic approaches to Guillain-Barré syndrome.
    Pritchard J
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2307-18. PubMed ID: 11060808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over intravenous immunoglobulin.
    Buzzigoli SB; Genovesi M; Lambelet P; Logi C; Raffaelli S; Cattano D
    Anaesth Intensive Care; 2010 Mar; 38(2):387-9. PubMed ID: 20369779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2010 Jun; (6):CD002063. PubMed ID: 20556755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002063. PubMed ID: 16437439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
    Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barré syndrome.
    Rosca EC; Rosca O; Simu M
    Int Immunopharmacol; 2015 Dec; 29(2):964-965. PubMed ID: 26428850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
    Korinthenberg R
    Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847
    [No Abstract]   [Full Text] [Related]  

  • 19. Splenic rupture associated with primary CMV infection, AMSAN, and IVIG.
    de Havenon A; Davis G; Hoesch R
    J Neuroimmunol; 2014 Jul; 272(1-2):103-5. PubMed ID: 24856574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.